Collagen-Containing Fillers: Alone and in Combination

Clinics in Plastic Surgery

Volumn 33, Issue 4, 2006, Pages 587-596

  Baumann, Leslie ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTIOXIDANT; ANTIVIRUS AGENT; BOTULINUM TOXIN A; COLLAGEN IMPLANT; CORTICOSTEROID; CYCLOSPORIN; ELASTIN; FILLER; HYALURONIC ACID; LIDOCAINE; NONSTEROID ANTIINFLAMMATORY AGENT; POLY(METHYL METHACRYLATE); POLYLACTIC ACID; RETINOID; SUNSCREEN; TSUKUBAENOLIDE;

AGING; ALLERGIC REACTION; BIOENGINEERING; CUTANEOUS PARAMETERS; HERPES VIRUS INFECTION; HUMAN; IMPLANTATION; INJECTION; PHYSICIAN; REVIEW; SKIN BRUISING; SKIN CARE; SKIN DEFECT; TREATMENT INDICATION; WRINKLE;

COLLAGEN; DRUG THERAPY, COMBINATION; FACE; HUMANS; HYALURONIC ACID; LIP; REJUVENATION;

EID: 33750577029     PISSN: 00941298     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cps.2006.08.001     Document Type: Review

References (51)

1. Epstein Jr. E.H. (Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life. J Biol Chem (1974) 249(10):3225-31
2. Fenske N.A., and Lober C.W. Structural and functional changes of normal aging skin. J Am Acad Dermatol 15 4 Pt 1 (1986) 571-585
3. Lavker R.M. Structural alterations in exposed and unexposed aged skin. J Invest Dermatol 73 1 (1979) 59-66
4. Lovell C.R., Smolenski K.A., Duance V.C., et al. Type I and III collagen content and fibre distribution in normal human skin during ageing. Br J Dermatol 117 4 (1987) 419-428
5. Fisher G.J., Datta S.C., Talwar H.S., et al. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 379 6563 (1996) 335-339
6. Fisher G.J., Wang Z.Q., Datta S.C., et al. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 337 20 (1997) 1419-1428
7. Griffiths C.E., Russman A.N., Majmudar G., et al. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 329 8 (1993) 530-535
8. Talwar H.S., Griffiths C.E., Fisher G.J., et al. Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol 105 2 (1995) 285-290
9. Bergeret-Galley C. Comparison of resorbable soft tissue fillers. Aesthetic Surgery Journal 24 (2004) 33-46
10. Piacquadio D., Larson N.E., Denlinger J.L., et al. Hylan B gel (Hylaform) as a soft tissue augmentation material. In: Klein A.W. (Ed). Tissue augmentation in clinical practice: procedures and techniques (1997), Marcel Dekker, New York
11. Haake A., and Holbrook K. The structure and development of skin. In: Freedberg I.M., Eisen A.Z., Wolff K., et al. (Eds). Fitzpatrick's dermatology in general medicine. Vol. 1 5th edition (1999), McGraw Hill, New York 89-90
12. Ghersetich I., Lotti T., Campanile G., et al. Hyaluronic acid in cutaneous intrinsic aging. Int J Dermatol 33 (1994) 119-122
13. Milewicz D.M., Urban Z., and Boyd C. Genetic disorders of the elastic fiber system. Matrix Biol 19 6 (2000) 471-480
14. Escoffier C., de Rigal J., Rochefort A., et al. Age-related mechanical properties of human skin: an in vivo study. J Invest Dermatol 93 (1989) 353-357
15. Boente M.C., Winik B.C., and Asial R.A. Wrinkly skin syndrome: ultrastructural alterations of the elastic fibers. Pediatr Dermatol 16 (1999) 113-117
16. Neuber F. Fettransplantation. Chir Kongr Verhandl Dsch Gesellch Chir 22 (1893) 66
17. Klein A.W., and Elson M.L. The history of substances for soft tissue augmentation. Dermatol Surg 26 12 (2000) 1096-1105
18. Baumann L. Soft tissue augmentation. In: Baumann L. (Ed). Cosmetic dermatology: principles and practice (2002), McGraw-Hill, New York 155-172
19. Clark D.P., Hanke C.W., and Swanson N.A. Dermal implants: safety of products injected for soft tissue augmentation. J Am Acad Dermatol 21 5 Pt 1 (1989) 992-998
20. Klein A.W. Injectable collagen. In: Moschells S.L., and Hurley H.J. (Eds). Dermatology (1992), WB Saunders, Philadelphia 2455-2461
21. Hanke C.W., and Coleman III W.P. Dermal filler substances. In: Asken S., Alt T.H., Hanke C.W., et al. (Eds). Cosmetic surgery of the skin (1997), Mosby-Year Book, St. Louis (MO) 217-230
22. Hanke C.W., Higley H.R., Jolivette D.M., et al. Abscess formation and local necrosis after treatment with Zyderm or Zyplast collagen implant. J Am Acad Dermatol 25 2 Pt 1 (1991) 319-326
23. Stegman S.J., Chu S., and Armstrong R.C. Adverse reactions to bovine collagen implant: clinical and histologic features. J Dermatol Surg Oncol 14 (1988) 39-48
24. Elson M.L. The role of skin testing in the use of collagen injectable materials. J Dermatol Surg Oncol 15 3 (1989) 301-303
25. Castrow II F.F., and Krull E.A. Injectable collagen implant-update. J Am Acad Dermatol 9 6 (1983) 889-893
26. Siegle R.J., McCoy Jr. J.P., Schade W., et al. Intradermal implantation of bovine collagen. Humoral immune responses associated with clinical reactions. Arch Dermatol 120 2 (1984) 183-187
27. Klein A.W., and Rish D.C. Injectable collagen update. J Dermatol Surg Oncol 10 7 (1984) 519-522
28. Klein A.W. In favor of double testing. J Dermatol Surg Oncol 15 3 (1989) 263
29. Baumann L.S., and Kerdel F. The treatment of bovine collagen allergy with cyclosporin. Dermatol Surg 25 3 (1999) 247-249
30. Moody B.R., and Sengelmann R.D. Topical tacrolimus in the treatment of bovine collagen hypersensitivity. Dermatol Surg 27 9 (2001) 789-791
31. Cukier J., Beauchamp R.A., Spindler J.S., et al. Association between bovine collagen dermal implants and a dermatomyositis or a polymyositis-like syndrome. Ann Intern Med 118 12 (1993) 920-928
32. Hanke C.W., Thomas J.A., Lee W.T., et al. Risk assessment of polymyositis/dermatomyositis after treatment with injectable bovine collagen implants. J Am Acad Dermatol 34 3 (1996) 450-454
33. Rosenberg M.J., and Reichlin M. Is there an association between injectable collagen and polymyositis/dermatomyositis?. Arthritis Rheum 37 5 (1994) 747-753
34. Elson M.L. Injectable collagen and autoimmune disease. J Dermatol Surg Oncol 19 2 (1993) 165-168 [discussion: 170]
35. Lemperle G., Gauthier-Hazan N., and Lemperle M. PMMA-microspheres (Artecoll) for long-lasting correction of wrinkles: refinements and statistical results. Aesthetic Plast Surg 22 5 (1998) 356-365
36. Cohen S.R., and Holmes R.E. Artecoll: a long-lasting injectable wrinkle filler material: report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 114 4 (2004) 964-976 [discussion: 977-9]
37. Broder K.W., and Cohen S.R. ArteFill: a permanent skin filler. Expert Rev Med Devices 3 3 (2006) 281-289
38. Lemperle G., Romano J.J., and Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 29 6 (2003) 573-587 [discussion: 587]
39. Perret S., Eble J.A., Siljander P.R., et al. Prolyl hydroxylation of collagen type I is required for efficient binding to integrin alpha 1 beta 1 and platelet glycoprotein VI but not to alpha 2 beta 1. J Biol Chem 278 32 (2003) 29873-29879
40. Okada S., Hagan J.B., Kato M., et al. Lidocaine and its analogues inhibit IL-5-mediated survival and activation of human eosinophils. J Immunol 160 8 (1998) 4010-4017
41. Baumann L. CosmoDerm/CosmoPlast (human bioengineered collagen) for the aging face. Facial Plast Surg 20 2 (2004) 125-128
42. Larsen N.E., Pollack C.T., Reiner K., et al. Hylan Gel biomaterial: dermal and immunologic compatibility. J Biomed Mater Res 27 (1993) 1129-1134
43. Balazs E.A., Bland P.A., Denlinger J.L., et al. Matrix engineering. Blood Coagul Fibrinolysis 2 1 (1991) 173-178 [review]
44. Transcript from the General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee of the FDA on November 21, 2003. Available at: http://www.fda.gov/ohrms/dockets/ac/03/transcripts/4004T1.htm and http://www.fda.gov/ohrms/dockets/ac/03/transcripts/4004T1_01.htm.
45. Narins R.S., Brandt F., Leyden J., et al. A randomized, double-blind multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 29 (2003) 588-595
46. Malson T, Lindqvist B. Ge of crosslinked hyaluronic acid for use as a vitreous humor substitute. European Patent 0185070; 1985.
47. Narins RS. Soft tissue augmentation course. American Academy of Dermatology, February 2004.
48. Vercruysse K.P., Marecak D.M., Marecek J.F., et al. Synthesis and in vitro degradation of new polyvalent hydrazide cross-linked hydrogels of hyaluronic acid. Bioconjug Chem 8 (1997) 686-694
49. Barbucci R., Lamponi S., Magnani A., et al. The influence of molecular weight on the biological activity of heparin like sulphated hyaluronic acids. Biomaterials 19 7-9 (1998) 801-806
50. Pandolfi M., and Hedner U. The effect of sodium hyaluronate and sodium chondroitin sulfate on the coagulation system in vitro. Ophthalmology 91 7 (1984) 864-866
51. Baumann L. How to prevent photoaging. J Invest Dermatol 125 4 (2005) xii-xiii